Description
RETATRUTIDE 10MG
10mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
Retatrutide is an experimental peptide within the incretin class, acting as a triple agonist of the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and GCGR (glucagon) receptors. Within experimental protocols, this molecule is studied for its unprecedented synergistic impact on insulin regulation, energy expenditure, and lipid oxidation
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | Retatrutide 10mg |
| Sequence | Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-α-Me-Leu-Leu-Asp-Lys-diacid-C20-γ-Glu-(AEEA)-Lys-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Molecular Formula | C221H342N46O68 |
| Molecular Weight | 4731.33 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 10 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
Retatrutide 10mg Research Application Areas
Current laboratory studies on Retatrutide 10mg focus on the following key research areas:
- Triple Hormonal Agonism: Study of the simultaneous activation of GLP-1, GIP, and Glucagon receptors on glucose homeostasis.
- Lipid Metabolism: Research on increased lipolysis and the reduction of hepatic steatosis (fatty liver) in biological models.
- Energy Expenditure: Analysis of the specific impact of the glucagon receptor on elevating the basal metabolic rate.
- Weight Regulation: Study of central satiety mechanisms and the reduction of caloric intake.
Looking for another Retatrutide 10mg alternative? Explore our full range of Research Peptides.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
